Athersys (NASDAQ:ATHX) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX) in a research report report published on Thursday. The brokerage issued a hold rating on the biopharmaceutical company’s stock.

Athersys Price Performance

Shares of ATHX opened at $0.01 on Thursday. Athersys has a 52 week low of $0.01 and a 52 week high of $1.99. The stock has a market capitalization of $833,206.50, a price-to-earnings ratio of -0.01 and a beta of -0.90.

About Athersys

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.